공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

외골격 시장 : 성장, 동향, COVID-19의 영향 및 예측(2021-2026년)

Exoskeleton Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2021년 05월 상품 코드 1008405
페이지 정보 영문
US $ 4,250 ₩ 5,044,000 PDF (Single User License)
US $ 4,750 ₩ 5,637,000 PDF (Team License: Up to 7 Users)
US $ 6,000 ₩ 7,121,000 PDF (Site License)
US $ 7,500 ₩ 8,901,000 PDF (Corporate License)

외골격 시장 : 성장, 동향, COVID-19의 영향 및 예측(2021-2026년) Exoskeleton Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
발행일 : 2021년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

외골격 시장 규모는 2020-2026년의 예측 기간 중 12.5%의 CAGR로 확대할 것으로 예측됩니다.

COVID-19 팬데믹은 시장에 약간의 악영향을 미칠 것으로 보이고 있습니다. 이 시장에 대한 COVID-19의 영향은 2020년의 록다운 시나리오에 기인합니다. 발생에 의해 주로 영향을 받는 인구는 외골격을 가장 많이 사용하는 고령자 그룹이며, 모든 재활 센터가 폐쇄되거나 부분적으로만 개방하고 있으므로 긴급사태에 이것에 접근하는 옵션은 없습니다. 트레이닝과 딜리버리도 모든 조건이 고려될 때까지 제한됩니다. 또한 어포인트먼트는 보류되고 있으며, 상황이 개선되면서 필요에 따라 2020년에 계획되고 있던 트레이닝 프로그램의 스케줄 변경 가능성이 있습니다. 많은 국가가 현재도 봉쇄되고 있으며, 다른 국가와의 무역도 정지하고 있으므로 시장에서의 외골격 주문이 감소하고 있습니다. 직접 판매 활동에는 즉각적인 영향이 있으며, 주요 기업의 많은 기업 판매에 영향을 미칠 것으로 보이고 있습니다.

뇌졸중의 유병률 상승, 외골격의 채택 증가 및 세계 레벨에서 고령자 인구의 증가는 예측 기간 중 시장의 성장에 영향을 미칠 것으로 예상되는 주요 요인의 일부입니다. 장애인 및 고령자의 증가에 수반하여 전 세계에서 로봇에 의한 재활의 수요가 높아지고 있습니다. 최근 인구 고령화로 인해 물리치료 서비스의 수요가 높아지고 있습니다. 뇌졸중 등 의학적 장애로부터의 생존률 향상에 의해 헬스케어에서에서 테크놀러지의 역할이 입증되었습니다. 따라서 로봇 재활과 지원 기술은 물리치료 스탭에 대한 스트레스를 경감하고, 환자의 삶의 질을 향상시키면서 비용을 억제할 것으로 보이고 있습니다.

외골격 시장에 대해 조사했으며, 시장의 개요와 치료 유형별, 신체 부위별, 제품 유형별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 정리하여 전해드립니다.


제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장 역학

  • 시장 개요
  • 시장 촉진요인
    • 로봇 재활을 위한 헬스케어 부문으로부터의 수요 증가
    • 로봇 기술의 진보
    • 외골격 기술의 개발을 위한 거액의 투자
  • 시장 억제요인
    • 애매한 안전 가이드라인에 의한 외골격의 사용에 수반하는 리스크
  • Porter's Five Forces 분석

제5장 시장 세분화

  • 치료 유형별
    • 재활
    • 증강
  • 신체 부위별
    • 상반신
    • 하반신
  • 제품 유형별
    • 고정형
    • 이동형
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 중동과 아프리카
    • 남미

제6장 경쟁 구도

  • 기업 개요
    • Cyberdyne Inc.
    • Ekso Bionics Holdings
    • Rewalk Robotics
    • Bionik Laboratories Corp.
    • Parker-Hannifin Corp.
    • Bioservo Technologies AB
    • Gogoa Mobility Robots
    • Rehab-Robotics Company Limited
    • Bioness Inc.
    • B-Temia Inc.

제7장 시장 기회 및 향후 전망

KSA 21.06.17

The exoskeleton market is expected to register a CAGR of 12.5% during the forecast period from 2020-2026.

The COVID-19 pandemic is likely to have a slight negative impact on the market. The impact of the COVID-19 on the market studied is attributed to the scenario of lockdown in 2020. Due to the outbreak, the majorly affected population is the geriatric group who use exoskeleton the most, and as all the rehabilitation centers are either closed or partly open, people do not have an option to approach these even in an emergency situation. The training and delivery are also limited until all conditions are deemed. In addition, appointments are on hold and as the situation gets to be better, rescheduling of training programs may occur that had been planned for 2020 as needed. Many countries are still in lockdown now and have also suspended trades with other countries, leading to a decline in the orders of exoskeletons in the market. There is an immediate impact on direct sales activities, which may impact many of the company sales of major players.

The major factors propelling the market growth are the rising prevalence of stroke, increasing adoption of the exoskeleton, and growing geriatric population at a global level are some of the key factors anticipated to influence the market growth over the forecast period. With the increasing number of disabled and aged people, there has been an increase in the demand for robotic rehabilitation around the world. In recent years, the demand for physical therapy services has grown, partly because of the aging population. The role of technology in healthcare has become evident with the enhanced rate of survival from medical disorders, such as stroke. Robotic rehabilitation and assistive technologies, therefore, promise to ease stress on the physiotherapy staff and control expenses while refining patients' quality of life.

There has been a growing demand for these robotic rehabilitation devices that is showing an upward trajectory as the prevalence of disability around the world is increasing. According to the WHO 2018 statistics, over a billion people are being estimated to live with some form of disability. This corresponds to about 15% of the world's population. Between 110 million (2.2%) and 190 million (3.8%) people 15 years and older have significant difficulties in their functioning. More importantly, the report states that the disabled population is expanding, mainly owing to the rising geriatric population. For example, the UN's population estimates that the global geriatric population is expected to reach 2.1 billion by 2050. Furthermore, the rates of disability are increasing, in part due to ageing populations and an increase in chronic health conditions. Therefore the applications of robotic rehabilitation are growing fast, as is the market for these systems. One example is a robot developed at McGill University that helps wheelchair-bound patients to rise and walk. It supports in gait training and neuro-rehabilitation. Other researchers and companies are also found developing products using robotics and 3D printing to help patients with movement disorders from an impaired spinal cord or due to stroke, Parkinson's disease, and multiple sclerosis. In addition, there are also numerous hospitals that have started using robotics within their rehabilitation centers. Hence, all these factors are expected to drive the overall market.

Key Market Trends

Mobile Segment is Expected to Hold the Largest Share of Market in the Product Type Over the Forecast Period

Mobile exoskeletons can be worn outside or in a person's home. They require a battery pack and light motors and controllers that are fitted in a limited, compact space. This factor makes the designing of mobile exoskeletons highly complicated and expensive. Mobile exoskeletons support the powered hip and knee motion to help individuals with spinal cord injuries to stand and walk. Exoskeletons can cover the entire body or even a specific body segment, such as the ankle or the hip. They also consist of tethered exoskeletons that are suspended on an overhead guide rail, supported by a metal frame on wheels, or the exoskeleton can be directly supported by a mobile robot. These tethered exoskeletons also have large motors and controllers and none of their weight is distributed to the user. They are also gaining increasing popularity in the market due to their lightweight construction, as compared to the bulky metal or plastic exoskeletons. According to an article titled "Mobile Exoskeleton for Spinal Cord Injury: Development and Testing", eLEGS was developed for people who have lost the ability to walk due to paralysis or other injuries. The device is a mobile exoskeleton with actuated sagittal plane hip and knee joints. It supports the user and moves their legs through a natural gait.

The device uses a multi-leveled controller that consists of a state machine to determine the user's intended motion, a trajectory generator to establish desired joint behavior, and a low-level controller to calculate individual joint controller output. The system can be controlled by a physical therapist or by the user. The advantages and benefits while using mobile exoskeletons are expected to boost market growth.

North America is Expected to Hold a Significant Share of the Market Over the the Forecast Period

The key factors responsible for the large share of the North American region includes the high purchasing power of patients, growing geriatric population, and presence of public and private organizations offering grants & funds for the development of technologically advanced products.

According to the 2018 estimates by the Internet Stroke Center, stroke is the leading cause of serious, long-term disabilities in the United States. Approximately 17 million Americans suffer from stroke every year, and more than one million survivors sustain functional limitations in their daily activities due to stroke. More than 50% of stroke survivors experience long-term walking impairment, due to hemiplegia or hemiparesis. Impaired ambulation due to hemiparesis or hemiplegia is associated with increased fall risk, limited community participation, and an overall decrease in the quality of life. Furthermore, the increasing prevalence of spinal cord injury (SCI) is one of the leading factors that may increase the adoption of the exoskeleton in the United States. According to the National Spinal Cord Injury Statistical Center (NSCISC), approximately 12,500 new cases of spinal cord injury (SCI) were reported in the United States in 2015. In 2018, the number of cases of SCI was nearly 17,700 and around 17,730 in 2019. Currently, about 363,000 people in the country are living with these injuries. Thus, a rise in the spinal cord injury- (SCI) and stroke-associated disability factor is expected to boost the growth of the market in the country, in the coming years.

Competitive Landscape

The market is moderately consolidated. Some of the key players in the market studied are Cyberdyne, Ekso Bionics Holdings, Rewalk Robotics, Bionik Laboratories and among others. Therefore the increasing investments by these players in the development of new and innovative products and FDA approvals on their products are supporting the market growth. For example, in January 2020, Bioservo Technologies announced the launch of its Ironhand 1.6 version for an optimized user experience for its patients.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support



  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Demand From Healthcare Sector for Robotic Rehabilitation
    • 4.2.2 Advancement in Robotic Technologies
    • 4.2.3 Huge Investment for the Development of the Exoskeleton Technology
  • 4.3 Market Restraints
    • 4.3.1 Risks Involved With Using Exoskeletons Due to Vague Safety Guidelines
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Treatment Type
    • 5.1.1 Rehabilitation
    • 5.1.2 Augmentation
  • 5.2 By Body Part Type
    • 5.2.1 Upper Body
    • 5.2.2 Lower Body
  • 5.3 By Product Type
    • 5.3.1 Stationary
    • 5.3.2 Mobile
  • 5.4 Geography
    • 5.4.1 North America
      • United States
      • Canada
      • Mexico
    • 5.4.2 Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • 5.4.3 Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • GCC
      • South Africa
      • Rest of Middle East and Africa
    • 5.4.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 Cyberdyne Inc.
    • 6.1.2 Ekso Bionics Holdings
    • 6.1.3 Rewalk Robotics
    • 6.1.4 Bionik Laboratories Corp.
    • 6.1.5 Parker-Hannifin Corp.
    • 6.1.6 Bioservo Technologies AB
    • 6.1.7 Gogoa Mobility Robots
    • 6.1.8 Rehab-Robotics Company Limited
    • 6.1.9 Bioness Inc.
    • 6.1.10 B-Temia Inc.


Back to Top
전화 문의